423
Participants
Start Date
February 5, 2018
Primary Completion Date
September 26, 2018
Study Completion Date
September 26, 2018
EN3835
Collagenase clostridium histolyticum
Placebo
Placebo
Endo Clinical Trial Site #21, New York
Endo Clinical Trial Site #19, New York
Endo Clinical Trial Site #20, New York
Endo Clinical Trial Site #18, Mount Kisco
Endo Clinical Trial Site #26, Charlottesville
Endo Clinical Trial Site #10, Snellville
Endo Clinical Trial Site #9, Miami
Endo Clinical Trial Site #7, Boca Raton
Endo Clinical Trial Site #8, Largo
Endo Clinical Trial Site #22, Cincinnati
Endo Clinical Trial Site #15, Fridley
Endo Clinical Trial Site #11, Chicago
Endo Clinical Trial Site #16, Washington
Endo Clinical Trial Site #17, Omaha
Endo Clinical Trial Site #12, New Orleans
Endo Clinical Trial Site #23, Houston
Endo Clinical Trial Site #25, Sugar Land
Endo Clinical Trial Site #24, Pflugerville
Endo Clinical Trial Site #1, Scottsdale
Endo Clinical Trial Site #4, Los Angeles
Endo Clinical Trial Site #3, Long Beach
Endo Clinical Trial Site #2, Encinitas
Endo Clinical Trial Site #5, Oceanside
Endo Clinical Trial Site #6, San Diego
Endo Clinical Trial Site #13, Chestnut Hill
Endo Clinical Trial Site #14, Quincy
Lead Sponsor
Endo Pharmaceuticals
INDUSTRY